• Alisjahbana B, Sahiratmadja E, Nelwan EJ et al. (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clinical Infectious Diseases 45, 428435.
  • Başoğlu OK, Bacakoğlu F, Cok G, Sayiner A & Ateş M (1999) The oral glucose tolerance test in patients with respiratory infections. Monaldi Archives for Chest Disease 54, 307310.
  • Butt AA, McGinnis K, Rodriguez-Barradas MC et al. (2009) HIV infection and the risk of diabetes mellitus. AIDS 23, 12271234.
  • Calvet HM & Yoshikawa TT (2001) Infections in diabetes. Infectious Disease Clinics of North America 15, 407421, viii.
  • Dati F, Schumann G, Thomas L et al. (1996) Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. European Journal of Clinical Chemistry and Clinical Biochemistry 34, 517520.
  • Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H & Genetet B (1997) Impaired leucocyte functions in diabetic patients. Diabetic Medicine 14, 2934.
  • Exton MS (1997) Infection-induced anorexia: active host defence strategy. Appetite 29, 369383.
  • Faurholt-Jepsen D, Range N, Praygod G et al. (2011) Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from mwanza, Tanzania. PLoS One 6, e24215.
  • Gearhart MM & Parbhoo SK (2006) Hyperglycemia in the critically ill patient. AACN Clinical Issues 17, 5055.
  • Hendy M & Stableforth D (1983) The effect of established diabetes mellitus on the presentation of infiltrative pulmonary tuberculosis in the immigrant Asian community of an inner city area of the United Kingdom. British Journal of Diseases of the Chest 77, 8790.
  • IUATLD (2000) Technical Guide: Sputum Examination for Tuberculosis by Direct Microscopy in Low Income Countries. 5th edn International Union Against Tuberculosis and Lung Disease (IUATLD), Paris.
  • Joshi N, Caputo GM, Weitekamp MR & Karchmer AW (1999) Infections in patients with diabetes mellitus. New England Journal of Medicine 341, 19061912.
  • Lönnroth K, Castro KG, Chakaya JM et al. (2010) Tuberculosis control and elimination 2010-50: cure, care, and social development. The Lancet 375, 18141829.
  • Mboussa J, Monabeka H, Kombo M, Yokolo D, Yoka-Mbio A & Yala F (2003) Evolution de la tuberculose pulmonaire chez les diabétiques. Revue de Pneumologie Clinique 59, 3944.
  • McCowen KC, Malhotra A & Bistrian BR (2001) Stress-induced hyperglycemia. Critical Care Clinics 17, 107124.
  • Mohan V, Deepa M, Deepa R et al. (2006) Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India – the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 49, 11751178.
  • Muller LMAJ, Gorter KJ, Hak E et al. (2005) Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clinical Infectious Diseases 41, 281288.
  • Pozzilli P & Leslie RD (1994) Infections and diabetes: mechanisms and prospects for prevention. Diabetic Medicine 11, 935941.
  • PrayGod G, Range N, Faurholt-Jepsen D et al. (2011a) Weight, body composition and handgrip strength among pulmonary tuberculosis patients: a matched cross-sectional study in Mwanza, Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 105, 140147.
  • PrayGod G, Range N, Faurholt-Jepsen D et al. (2011b) Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania. The Journal of Nutrition 141, 685691.
  • Restrepo BI, Fisher-Hoch SP, Crespo JG et al. (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiology and Infection 135, 483491.
  • Swaminathan S, Padmapriyadarsini C & Narendran G (2010) HIV/AIDS: HIV-associated tuberculosis: clinical update. Clinical Infectious Diseases 50, 13771386.
  • Wang JY, Lee LN & Hsueh PR (2005) Factors changing the manifestation of pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease 9, 777783.
  • Wang CS, Yang CJ, Chen HC et al. (2009) Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiology and Infection 137, 203210.
  • WHO (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. (Accessed on 12 March 2009).
  • WHO (2009) Treatment of Tuberculosis: guidelines for national programmes. (Accessed on 1 March 2010).
  • Young F, Critchley JA, Johnstone LK & Unwin NC (2009) A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Global Health 5, 9.